PL3277083T3 - Zastosowanie kompozycji do prezerwacji narządów w celu prezerwacji narządu lub jego części - Google Patents

Zastosowanie kompozycji do prezerwacji narządów w celu prezerwacji narządu lub jego części

Info

Publication number
PL3277083T3
PL3277083T3 PL16727247.5T PL16727247T PL3277083T3 PL 3277083 T3 PL3277083 T3 PL 3277083T3 PL 16727247 T PL16727247 T PL 16727247T PL 3277083 T3 PL3277083 T3 PL 3277083T3
Authority
PL
Poland
Prior art keywords
organ
preserving
parts
preservation compositions
compositions
Prior art date
Application number
PL16727247.5T
Other languages
English (en)
Inventor
Benedict Marie Doorschodt
Original Assignee
Vivalyx Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vivalyx Gmbh filed Critical Vivalyx Gmbh
Publication of PL3277083T3 publication Critical patent/PL3277083T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00—Phosphorus; Compounds thereof
    • C01B25/16—Oxyacids of phosphorus; Salts thereof
    • C01B25/26—Phosphates
    • C01B25/30—Alkali metal phosphates
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D7/00—Carbonates of sodium, potassium or alkali metals in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/08—Polyethers derived from hydroxy compounds or from their metallic derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Physiology (AREA)
PL16727247.5T 2015-04-03 2016-04-01 Zastosowanie kompozycji do prezerwacji narządów w celu prezerwacji narządu lub jego części PL3277083T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2014584 2015-04-03
PCT/NL2016/050228 WO2016159773A1 (en) 2015-04-03 2016-04-01 Organ preservation composition

Publications (1)

Publication Number Publication Date
PL3277083T3 true PL3277083T3 (pl) 2025-05-26

Family

ID=56101775

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16727247.5T PL3277083T3 (pl) 2015-04-03 2016-04-01 Zastosowanie kompozycji do prezerwacji narządów w celu prezerwacji narządu lub jego części

Country Status (6)

Country Link
US (1) US10874098B2 (pl)
EP (1) EP3277083B1 (pl)
CA (1) CA2981588A1 (pl)
ES (1) ES3010496T3 (pl)
PL (1) PL3277083T3 (pl)
WO (1) WO2016159773A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021001205A (es) * 2018-07-30 2021-09-08 Acorn Biolabs Inc Composiciones para transporte y/o crioconservación de células y/o tejidos.
CN110352951A (zh) * 2018-11-15 2019-10-22 崔磊 一种无血清无dmso组织工程骨冻存液及其制备和冻存方法
CN109438555B (zh) * 2018-11-22 2022-07-29 浙江海洋大学 一种非天然抗氧化肽的制备方法
IT201900007446A1 (it) 2019-05-29 2020-11-29 Giuseppe Castellano Composizione comprendente citrato e carnitina in grado di attivare la produzione della proteina klotho
CN112167240A (zh) * 2019-07-02 2021-01-05 南京三生生物技术股份有限公司 临床级细胞冷藏保存液及其制备方法和应用
WO2021198865A1 (en) * 2020-03-28 2021-10-07 University Health Network Methods, compositions, and systems for enhancing ex-vivo organ perfusion
EP4338590A4 (en) * 2021-05-11 2025-04-30 Bmg Incorporated COLD STORAGE SOLUTION AND STORAGE METHOD FOR STEM CELLS
CA3220730A1 (en) * 2021-05-31 2022-12-08 Mingyao Liu Compositions and methods for lung preservation
CN114052008A (zh) * 2021-11-23 2022-02-18 中山大学附属第三医院（中山大学肝脏病医院） 一种保存液及其应用
WO2023201038A1 (en) * 2022-04-15 2023-10-19 Marizyme, Inc. Powder formulations and use thereof in medical and/or surgical procedures
CN115349514B (zh) * 2022-07-08 2024-02-27 杭州联川生物技术股份有限公司 一种新鲜组织冻存液及其制备方法和应用
EP4627054A1 (en) * 2022-12-01 2025-10-08 The Cleveland Clinic Foundation Perfusate compositions, methods, and systems
CN116459342A (zh) * 2023-03-27 2023-07-21 中国人民解放军总医院海南医院 一种用于急性心肌梗死闭塞血管远端的溶栓组合物
WO2024211696A1 (en) 2023-04-07 2024-10-10 Biogen Ma Inc. 1h-pyrrolo[2,3-b]pyridin-4-yl]-2-oxopyrrolidine-3-carbonitrile derivatives as tyrosine kinase 2 (tyk2) inhibitors for the treatment of inflammatory diseases
US20250049842A1 (en) * 2023-07-13 2025-02-13 James D. Ervin Therapeutic blood-acid-shifting compositions and methods
WO2025247851A1 (en) * 2024-05-27 2025-12-04 Artidis Ag Preservation reagents for biological samples and use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8105887L (sv) 1981-10-06 1983-04-07 Erland Johansson Blandning for human tillforsel av selen som sparemne
US4798824A (en) 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US4879283A (en) 1985-10-03 1989-11-07 Wisconsin Alumni Research Foundation Solution for the preservation of organs
US4923442A (en) 1988-05-02 1990-05-08 Cryomedical Sciences Inc. Blood substitute
US4920044A (en) 1988-11-08 1990-04-24 The Cleveland Clinic Foundation Intracellular flush solution for preserving organs
US4938961A (en) 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia
US5182299A (en) 1990-03-19 1993-01-26 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes
WO1991014435A1 (en) * 1990-03-19 1991-10-03 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes
US5599659A (en) 1993-03-11 1997-02-04 Breonics, Inc. Preservation solution for ex vivo, warm preservation of tissues, explants,organs and vascular endothelial cells comprising retinal-derived fibroblast growth factor, cyclodextrin and chondroitin sulfate
US5405742A (en) 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
US6153582A (en) 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
FR2785501B1 (fr) 1998-11-10 2001-01-05 Centre Nat Rech Scient Solution de perfusion et/ou de conservation et/ou de reperfusion lors de la transplantation d'organes
WO2000032140A1 (en) 1998-11-30 2000-06-08 Ivf Sciences Colorado, Inc. System and sequential culture media for in vitro fertilization
FR2793651B1 (fr) 1999-05-18 2003-05-16 Cair L G L Solution aqueuse de conservation de tissus et d'organes
US6492103B1 (en) * 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
CN100381048C (zh) 2000-11-03 2008-04-16 维特罗莱夫股份公司 评价和保存溶液
US8637230B2 (en) * 2004-11-12 2014-01-28 Organoflush B.V. Composition for cold preservation and perfusion of organs
EP1782797A1 (en) * 2005-11-02 2007-05-09 Pharmatex Italia Srl Process for the preparation of sterile powdered pharmaceutical compounds.
IL301141A (en) * 2006-04-19 2023-05-01 Transmedics Inc Systems and methods for ex vivo organ care
US7892724B2 (en) * 2007-07-12 2011-02-22 Warsaw Orthopedic, Inc Method for enhancing the viability of mammalian cells, tissues and organs using a solution comprising two low molecular weight PEGs
US20090226876A1 (en) * 2007-11-19 2009-09-10 THE UNITED STATES GOVERMENT as represented by the DEPARTMENT OF VETERAN'S AFFAIRS Compositions And Methods For Cardiovascular Surgery

Also Published As

Publication number Publication date
US10874098B2 (en) 2020-12-29
CA2981588A1 (en) 2016-10-06
EP3277083C0 (en) 2025-01-22
ES3010496T3 (en) 2025-04-03
EP3277083B1 (en) 2025-01-22
EP3277083A1 (en) 2018-02-07
WO2016159773A1 (en) 2016-10-06
US20180070582A1 (en) 2018-03-15

Similar Documents

Publication Publication Date Title
PL3277083T3 (pl) Zastosowanie kompozycji do prezerwacji narządów w celu prezerwacji narządu lub jego części
EP3660122A4 (en) COOLANT COMPOSITION
DK3240415T3 (da) Fungicide sammensætninger
PL4275512T3 (pl) Kompozycje jadalne o wysokiej wilgotności
DK3495023T3 (da) Semifluorerede forbindelser og sammensætninger deraf
EP3137270C0 (en) Wood preservative composition
IL257784A (en) Pharmaceutical composition used for reducing localised fat and use of pharmaceutical composition
PL3484469T3 (pl) Kompozycje i sposoby do wzmacniania działania środków przeciwdrobnoustrojowych
DK3494119T3 (da) Forbindelser og sammensætninger og anvendelser deraf
PL3261437T3 (pl) Grzybobójcze związki i kompozycje
MA50787A (fr) Compositions fongicides
DK3288379T3 (da) Peptidsammensætninger og anvendelsesmåder
EP3443078A4 (en) ANTIMICROBIAL COMPOSITIONS
EP3674359A4 (en) LATEX COMPOSITION
EP4234657C0 (en) Compositions
IL266833B (en) Organ preservation preparations
DK3451829T3 (da) Antimikrobielle sammensætninger
IL264445A (en) Compounds and compositions and uses thereof
IL275739A (en) Preparations for cryopreservation and methods of their use
DK3217978T3 (da) Sammensætninger omfattende substitueret benzofuroquinolizin og alpha2-adrenerge agonister
EP3683264A4 (en) ENCAPSULATION COMPOSITION
PL3528791T3 (pl) Kompozycje dyspergowalne
EP3681468C0 (en) ANTIMICROBIAL COMPOSITION
EP3594284A4 (en) COMPOSITION OF LATEX
EP3428254A4 (en) Grease composition